Association between exenatide use and incidence of Alzheimer's disease

Association between exenatide use and incidence of Alzheimer's disease

Abstract Introduction Recent developments suggest that insulin‐sensitizing agents used to treat type II diabetes (T2DM) may also prove useful in reducing the risk of Alzheimer's disease (AD). The objective of this study is to analyze the association between exenatide use among Medicare benefici...

Full description

Bibliographic Details
Main Authors: Bo Zhou, Julie Zissimopoulos, Hasan Nadeem, Matthew A. Crane, Dana Goldman, John A. Romley
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
Alzheimer's disease incidence
diabetes
exenatide
prevention
Online Access:https://doi.org/10.1002/trc2.12139

Similar Items

Similar Items